Ricardo Correa Marquez, MD
Endocrinology, Diabetes & Metabolism · East Providence, RINPI 1053623538
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 26.0% of the total. 2025 is the largest year on record at $48,350, more than ten times the $224 reported in 2019. Among endocrinology, diabetes & metabolism clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $1053.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$24K
- Sanofi-aventis U.S. LLC$14K
- Recordati_rare_diseases_inc.$9K
- Corcept Therapeutics$9K
- Neurocrine Biosciences, Inc.$8K
- Ascendis Pharma Endocrinology Inc$7K
- plus $22K from 13 others
Across 3 payments — averaging $38,192 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Recordati_rare_diseases_inc.$115K
What the payments were for
- Consulting fees$51,85655%
- Speaking & faculty fees$27,20529%
- Travel & lodging$11,15812%
- Food & beverage$3,5364%
- Education$00%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 7 | $24,376 |
| Sanofi-aventis U.S. LLC | 5 | $14,192 |
| Recordati_rare_diseases_inc. | 5 | $9,292 |
| Corcept Therapeutics | 15 | $8,897 |
| Neurocrine Biosciences, Inc. | 11 | $8,177 |
| Ascendis Pharma Endocrinology Inc | 9 | $6,754 |
| Modernatx, Inc. | 4 | $6,119 |
| Chiesi USA, Inc. | 4 | $5,034 |
| Nestle Healthcare Nutrition Inc. | 9 | $4,214 |
| Abbott | 7 | $2,685 |
| Boehringer Ingelheim International GmbH | 1 | $1,665 |
| Pfizer | 2 | $1,250 |
| AstraZeneca | 1 | $675 |
| Amgen | 2 | $231 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| Johnson & Johnson | 3 | $55 |
| Shire North American Group Inc | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Travere Therapeutics, Inc. | 1 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$14,192
- ISTURISA$9,245
- Korlym$8,672
- Moderna Covid-19 Vaccine$6,097
- MYCAPSSA$2,425
- FreeStyle Libre$2,351
- JARDIANCE$1,665
- PREVNAR 20$875
- TEPEZZA$231
- MYALEPT$130
- Proclaim IPG$109
How this compares
$93,756 in reported general payments places this provider in the 90th percentile of 30 endocrinology, diabetes & metabolism providers in Rhode Island.
See all endocrinology, diabetes & metabolism providers in Rhode Island →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $156 |
| Dexamethasone | 18 | $11 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in East Providence
- Robert DobrzynskiProvidence$245K
- Frank D'alessandroNorth Providence$193K
- Robert SmithProvidence$80K
- Sudhir BansalWarwick$38K
- Joseph TucciProvidence$30K
- Judith GilmoreWakefield$11K
- Stephanie CurryJohnston$8K
- Beatriz DemoranvilleWarwick$5K
- Raquel CarneiroRiverside$3K
- Manchin ChangProvidence$878
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.